The signaling properties and functions of protease-activated receptor (PAR)1 and PAR2 in cardiomyocytes

被引：0
|
作者：
Sabri, A
Andrade-Gordon, P
Darrow, AL
Johnson, RW
Franke, TF
Steinberg, SF
机构：
[1] Columbia Univ, New York, NY USA
[2] RW Johnson Pharmaceut Res Inst, Spring House, PA 19477 USA
来源：
CIRCULATION | 1999年 / 100卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
28
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [41] Protease activated receptor-2 (PAR2): possible target of phytochemicals
    Kakarala, Kavita Kumari
    Jamil, Kaiser
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 (09): : 2003 - 2022
  • [42] Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC)
    Tomomitsu Tahara
    Tomoyuki Shibata
    Masakatsu Nakamura
    Hiromi Yamashita
    Daisuke Yoshioka
    Masaaki Okubo
    Naoko Maruyama
    Toshiaki Kamano
    Yoshio Kamiya
    Hiroshi Fujita
    Yoshihito Nakagawa
    Mitsuo Nagasaka
    Masami Iwata
    Kazuya Takahama
    Makoto Watanabe
    Hiroshi Nakano
    Ichiro Hirata
    Tomiyasu Arisawa
    Clinical and Experimental Medicine, 2009, 9 : 125 - 130
  • [43] Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC)
    Tahara, Tomomitsu
    Shibata, Tomoyuki
    Nakamura, Masakatsu
    Yamashita, Hiromi
    Yoshioka, Daisuke
    Okubo, Masaaki
    Maruyama, Naoko
    Kamano, Toshiaki
    Kamiya, Yoshio
    Fujita, Hiroshi
    Nakagawa, Yoshihito
    Nagasaka, Mitsuo
    Iwata, Masami
    Takahama, Kazuya
    Watanabe, Makoto
    Nakano, Hiroshi
    Hirata, Ichiro
    Arisawa, Tomiyasu
    CLINICAL AND EXPERIMENTAL MEDICINE, 2009, 9 (02) : 125 - 130
  • [44] Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions
    Bilodeau, Matthew L.
    Hamm, Heidi E.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 322 (02): : 778 - 788
  • [45] Selective effects of chronic hypertension on cerebral artery responses to protease-activated receptor-2 (PAR2) activation
    Sobey, CG
    Moffatt, JD
    Cocks, TM
    FASEB JOURNAL, 1999, 13 (05): : A1088 - A1088
  • [46] The E3-ubiquitin ligase c-Cbl regulates protease-activated receptor 2 (PAR2)
    Jacob, C
    Cottrell, G
    Schmidlin, F
    Grady, EF
    Bunnett, NW
    GASTROENTEROLOGY, 2004, 126 (04) : A413 - A413
  • [47] Role for proteases and protease-activated receptor-2 (par2) in pain associated with irritable bowel syndrome (IBS)
    Cenac, N
    Chapman, K
    Andrade-Gordon, P
    Ferraz, JG
    Andrews, C
    Shaffer, E
    Vergnolle, N
    GASTROENTEROLOGY, 2005, 128 (04) : A14 - A14
  • [48] Regulation of protease-activated receptor-1 (PAR1) trafficking
    Paing, MM
    Trejo, J
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 364A - 364A
  • [49] Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2
    Kanke, T
    Ishiwata, H
    Kabeya, M
    Saka, M
    Doi, T
    Hattori, Y
    Kawabata, A
    Plevin, R
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (02) : 255 - 263
  • [50] Protease-activated receptor-3 (PAR-3) acts as an allosteric modulator of PAR-1 signaling via receptor dimerization
    McLaughlin, Joseph N.
    Malik, Asrar B.
    FASEB JOURNAL, 2007, 21 (06): : A1430 - A1430
12345